Complete Protection against Lethal Toxoplasma gondii Infection in Mice Immunized with a Plasmid Encoding theSAG1 Gene

ABSTRACT Infection with the protozoan parasite Toxoplasma gondiiis transmitted to humans from infected animals by tissue cysts and oocysts excreted by cats. Immunization with inactivated parasites or recombinant proteins has at best shown partial protection. We constructed a plasmid expressing the SAG1 surface antigen of T. gondii, p1tPASAG1, and showed that animals immunized with the plasmid produce anti-SAG1 antibodies which recognize the native SAG1. Mice immunized with p1tPASAG1 showed 80 to 100% protection against challenge with the non-cyst-producing, virulent RH isolate, compared to an 80% mortality in mice immunized with empty plasmid, which is the greatest efficacy of any vaccine against T. gondii produced so far. The SAG1 molecule was analyzed for potential cytotoxic T-lymphocyte (CTL) epitopes, and four peptides with the best fit were synthesized. The ability of the peptides to stimulate gamma interferon production by CD8+ T cells from p1tPASAG1-immunized mice was tested in an ELISPOT assay, and one new CTL epitope was identified. Adoptive transfer of CD8+ T cells from p1tPASAG1-immunized to naı̈ve mice showed partial protection. In conclusion, DNA vaccination with p1tPASAG1 gave effective protection in mice againstT. gondii infection and the protection could be adoptively transferred by purified CD8+ T cells.

[1]  H. Nielsen,et al.  Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. , 1998, Vaccine.

[2]  E. Sandström,et al.  Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients , 1998, The Lancet.

[3]  Marion Becker,et al.  Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara , 1998, Nature Medicine.

[4]  Nielsen,et al.  Improved Humoral and Cellular Immune Responses Against the gp120 V3 Loop of HIV‐1 Following Genetic Immunization with a Chimeric DNA Vaccine Encoding the V3 Inserted into the Hepatitis B Surface Antigen , 1998, Scandinavian journal of immunology.

[5]  E. Raz,et al.  Gene vaccination: plasmid DNA is more than just a blueprint. , 1998, Immunology today.

[6]  Richard A. Morgan,et al.  Gene Therapy for Infectious Diseases , 1998, Clinical Microbiology Reviews.

[7]  N. Glaichenhaus,et al.  Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major , 1997, The Journal of experimental medicine.

[8]  T. Curiel,et al.  CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans , 1996, Infection and immunity.

[9]  J. Haynes,et al.  Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery , 1996, Journal of virology.

[10]  Søren Buus,et al.  Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding , 1996, European journal of immunology.

[11]  A. Sher,et al.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.

[12]  J. Vuust,et al.  Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies , 1996, Clinical and diagnostic laboratory immunology.

[13]  J. Montoya,et al.  Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells , 1996, Infection and immunity.

[14]  M. Manning,et al.  Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly. , 1995, The Journal of infectious diseases.

[15]  S. Buus,et al.  Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method. , 1995, Biochimica et biophysica acta.

[16]  T. Shirahata,et al.  CD8+ T Lymphocytes Are the Major Cell Population Involved in the Early Gamma Interferon Response and Resistance to Acute Primary Toxoplasma gondii Infection in Mice , 1994, Microbiology and immunology.

[17]  J. Boothroyd,et al.  Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells , 1994, Infection and immunity.

[18]  A. Sher,et al.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. , 1992, Journal of immunology.

[19]  J. Boothroyd,et al.  Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. , 1991, Journal of immunology.

[20]  D. Buxton,et al.  Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant , 1991, Veterinary Record.

[21]  C. Roberts,et al.  CD8+ T cells are the major lymphocyte subpopulatlon involved in the protective immune response to Toxoplasma gondii in mice , 1991, Clinical and experimental immunology.

[22]  A. Sher,et al.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. , 1991, Journal of immunology.

[23]  Y. Suzuki,et al.  The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. , 1990, Journal of immunology.

[24]  K. Lövgren,et al.  Trial of a novel experimental Toxoplasma iscom vaccine in pregnant sheep. , 1989, The British veterinary journal.

[25]  J. Boothroyd,et al.  Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. , 1988, Journal of immunology.

[26]  J. K. Frenkel,et al.  Live and killed vaccines against toxoplasmosis in mice. , 1983, The Journal of parasitology.

[27]  C. Roberts,et al.  Immunological control of Toxoplasma gondii and appropriate vaccine design. , 1996, Current topics in microbiology and immunology.

[28]  A. Lundén,et al.  Immune responses in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms. , 1995, Veterinary parasitology.

[29]  C. Roberts,et al.  Congenital toxoplasmosis in the Balb/c mouse: prevention of vertical disease transmission and fetal death by vaccination. , 1994, Vaccine.